ROANNE PARKER: Open Payments
NPI 1720274863 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 14 payments from 11 companies in 2025. Trend: 2023 $146 · 2024 $86 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
| Amgen Inc. | 2 | $31 |
| Tandem Diabetes Care, Inc. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Medtronic, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Gilead Sciences, Inc. | 1 | $15 |
Products named: Kerendia, REXULTI, FANAPT, t:slim X2 Insulin Pump with Control-IQ, VARIVAX, AIRSUPRA, MINIMED 780G, MOUNJARO.
Industry payments across AZ — which companies pay providers there.
